IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 672,000 (47%) | — | ₹148 Cr |
| Retail | — | 672,000 (47%) | — | ₹148 Cr |
| Market Maker | — | 72,000 (5%) | — | ₹2 Cr |
| Σ Total | — | 1,416,000 (100%) | — | ₹3,115 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 6,000 | ₹132,000 |
| Retail (Max) | 13 | 78,000 | ₹1,716,000 |
| S-HNI (Min) | 14 | 84,000 | ₹1,848,000 |
| B-HNI (Min) | 67 | 402,000 | ₹8,844,000 |
Financial Statements Amount in Lakhs
| Metric | 30-June-19 | 31-Mar-19 |
|---|---|---|
| Revenue | 182 | 56 |
| Profit After Tax | 34 | 7 |
| Total Assets | 797 | 782 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 To open processing center in nearby cites of Kanpur (Jhansi, Banda, Faizabad, Unnao) – 0.86
- 2 To purchase advanced machinery and equipment – 1.00
- 3 Repayment/pre-payment, of certain borrowings availed by the Company – 0.79
Company Overview
Incorporated in 2018, Kanpur (UP) based Gian Life Care Limited is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers.
The company offers over 1,344 tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services.
Gian Life is NABL accredited and ISO 9001:2015 certified company. It has 59 full-time employees.